Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Novo Nordisk ( (NVO) ) has fallen by -7.11%. Read on to learn why. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for...
Key Points In December, it earned approval for the oral version of its famous medicine. Novo Nordisk's newest product launch is proving very popular. It coul...
Novo Nordisk (NYSE:NVO) has launched an FDA approved oral version of its obesity drug Wegovy, expanding its GLP 1 obesity treatment portfolio. The company is w...
Analyst ratings
50%
of 34 ratingsMore NVO News
Novo Nordisk's weight loss pill could give the company's numbers a big boost this year. Novo Nordisk (NVO +0.06%) got fantastic news last year when regulators...
Key Points Eli Lilly CEO Dave Ricks said upcoming Medicare coverage of obesity drugs could be a major catalyst for the launch of the company's closely watched e...
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a multiyear anticompetitive scheme designed t...
TrumpRx — the government’s drug pricing initiative, which is at the center of the tariff deals the administration has reached with drugmakers since September —...
Technology How Roche Hopes To Go Toe-To-Toe With Eli Lilly, Novo Nordisk In Obesity Licensing Roche (RHHBY) hopes to go toe-to-toe with Eli Lilly (LLY) and Novo...
European pharmaceutical company Novo Nordisk (NVO) is spending twice as much as its U.S. rival Eli Lilly on weight-loss drug advertisements. Data from advertis...
If you are wondering whether Novo Nordisk's current share price still offers value, this article will walk through what the numbers say about the stock today....